Mehrdad Abedi

Title(s)Professor, Hematology and Oncology
SchoolSchool of Medicine
AddressCancer Ctr. So. # 3016
CA 95817
Phone916-734-3772
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. J Immunother Cancer. 2023 08; 11(8). Shah BD, Cassaday RD, Park JH, Houot R, Oluwole OO, Logan AC, Boissel N, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff PJ, Jeyakumar D, Mao D, Adhikary S, Zhou L, Schuberth PC, Damico Khalid R, Ghobadia A. PMID: 37648261; PMCID: PMC10471850.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Yttrium-90 ibritumomab tiuxetan plus ATG/TLI for allogeneic hematopoietic cell transplantation in non-Hodgkin lymphoma. Bone Marrow Transplant. 2023 10; 58(10):1143-1145. Othman T, Lowsky R, Richman C, Hoeg R, Abedi M, Tuscano J. PMID: 37391654.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care. Transplant Cell Ther. 2023 07; 29(7):460.e1-460.e9. Tomlinson B, de Lima M, Cogle CR, Thompson MA, Grinblatt DL, Pollyea DA, Komrokji RS, Roboz GJ, Savona MR, Sekeres MA, Abedi M, Garcia-Manero G, Kurtin SE, Maciejewski JP, Patel JL, Revicki DA, George TI, Flick ED, Kiselev P, Louis CU, DeGutis IS, Nifenecker M, Erba HP, Steensma DP, Scott BL. PMID: 37086851.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment. J Exp Clin Cancer Res. 2022 Dec 14; 41(1):344. Bota DA, Taylor TH, Piccioni DE, Duma CM, LaRocca RV, Kesari S, Carrillo JA, Abedi M, Aiken RD, Hsu FPK, Kong XT, Hsieh C, Bota PG, Nistor GI, Keirstead HS, Dillman RO. PMID: 36517865; PMCID: PMC9749349.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    5. Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study. J Hematol Oncol. 2022 12 10; 15(1):170. Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Dong J, Adhikary S, Zhou L, Schuberth PC, Faghmous I, Masouleh BK, Houot R. PMID: 36494725; PMCID: PMC9734710.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    6. Non-viral precision T cell receptor replacement for personalized cell therapy. Nature. 2023 03; 615(7953):687-696. Foy SP, Jacoby K, Bota DA, Hunter T, Pan Z, Stawiski E, Ma Y, Lu W, Peng S, Wang CL, Yuen B, Dalmas O, Heeringa K, Sennino B, Conroy A, Bethune MT, Mende I, White W, Kukreja M, Gunturu S, Humphrey E, Hussaini A, An D, Litterman AJ, Quach BB, Ng AHC, Lu Y, Smith C, Campbell KM, Anaya D, Skrdlant L, Huang EY, Mendoza V, Mathur J, Dengler L, Purandare B, Moot R, Yi MC, Funke R, Sibley A, Stallings-Schmitt T, Oh DY, Chmielowski B, Abedi M, Yuan Y, Sosman JA, Lee SM, Schoenfeld AJ, Baltimore D, Heath JR, Franzusoff A, Ribas A, Rao AV, Mandl SJ. PMID: 36356599; PMCID: PMC9768791.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCellsCTClinical Trials
    7. Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center. Leuk Res. 2022 08; 119:106885. Othman T, Moskoff BN, Ho G, Tenold ME, Azenkot T, Krackeler ML, Fisch SC, Potter LA, Kaesberg PR, Welborn JL, Wun T, Esteghamat NS, Hoeg RT, Rosenberg AS, Abedi M, Tuscano JM, Jonas BA. PMID: 35738024.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    8. Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects. Blood. 2021 12 16; 138(24):2583-2588. Khuat LT, Vick LV, Dunai C, Collins CP, More SK, Le CT, Pai CS, Stoffel KM, Maverakis E, Canter RJ, Monjazeb AM, Longo DL, Abedi M, Choi E, Blazar BR, Dave M, Murphy WJ. PMID: 34424962; PMCID: PMC8678998.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    9. Allogeneic hematopoietic cell transplantation using non-myeloablative ATG/TLI conditioning for lymphomas. Leuk Lymphoma. 2022 01; 63(1):231-234. Othman T, Moskoff BN, Esteghamat N, Hoeg RT, Rosenberg AS, Jonas BA, Abedi M, Richman C, Tuscano JM. PMID: 34486920.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Safety and tolerability of lenalidomide maintenance in post-transplant acute myeloid leukemia and high-risk myelodysplastic syndrome. Bone Marrow Transplant. 2021 12; 56(12):2975-2980. Pham B, Hoeg R, Krishnan R, Richman C, Tuscano J, Abedi M. PMID: 34471239; PMCID: PMC8636264.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    11. KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results. Blood. 2021 07 08; 138(1):11-22. Shah BD, Bishop MR, Oluwole OO, Logan AC, Baer MR, Donnellan WB, O'Dwyer KM, Holmes H, Arellano ML, Ghobadi A, Pagel JM, Lin Y, Cassaday RD, Park JH, Abedi M, Castro JE, DeAngelo DJ, Malone AK, Mawad R, Schiller GJ, Rossi JM, Bot A, Shen T, Goyal L, Jain RK, Vezan R, Wierda WG. PMID: 33827116; PMCID: PMC9999039.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    12. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study. Lancet. 2021 08 07; 398(10299):491-502. Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Feng C, Dong J, Shen T, Milletti F, Rossi JM, Vezan R, Masouleh BK, Houot R. PMID: 34097852.
      View in: PubMed   Mentions: 161     Fields:    Translation:HumansCTClinical Trials
    13. Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center. Front Oncol. 2021; 11:649209. Tenold ME, Moskoff BN, Benjamin DJ, Hoeg RT, Rosenberg AS, Abedi M, Tuscano JM, Jonas BA. PMID: 33777810; PMCID: PMC7991747.
      View in: PubMed   Mentions: 25  
    14. Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center. Clin Lymphoma Myeloma Leuk. 2021 07; 21(7):e611-e618. Tenold ME, Moskoff BN, Krishnan R, Rosenberg AS, Hoeg RT, Abedi M, Tuscano JM, Jonas BA. PMID: 33811007.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia. Am J Hematol. 2021 04 01; 96(4):E114-E117. Jonas BA, Fisch SC, Rosenberg AS, Hoeg RT, Tuscano JM, Abedi M. PMID: 33476436.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    16. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation. Sci Transl Med. 2020 11 25; 12(571). Khuat LT, Le CT, Pai CS, Shields-Cutler RR, Holtan SG, Rashidi A, Parker SL, Knights D, Luna JI, Dunai C, Wang Z, Sturgill IR, Stoffel KM, Merleev AA, More SK, Maverakis E, Raybould HE, Chen M, Canter RJ, Monjazeb AM, Dave M, Ferrara JLM, Levine JE, Longo DL, Abedi M, Blazar BR, Murphy WJ. PMID: 33239390; PMCID: PMC8525601.
      View in: PubMed   Mentions: 20     Fields:    Translation:Animals
    17. Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes. Int J Lab Hematol. 2021 Jun; 43(3):426-432. Patel JL, Abedi M, Cogle CR, Erba HP, Foucar K, Garcia-Manero G, Grinblatt DL, Komrokji RS, Kurtin SE, Maciejewski JP, Pollyea DA, Revicki DA, Roboz GJ, Savona MR, Scott BL, Sekeres MA, Steensma DP, Thompson MA, Dawn Flick E, Kiselev P, Louis CU, Nifenecker M, Swern AS, George TI. PMID: 33220019; PMCID: PMC8247031.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    18. Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia. J Hematol. 2020 Sep; 9(3):79-83. Tuscano J, Poh C, Rosenberg A, Jonas B, Abedi M, Barisone G, Schwab E, Lundeberg K, Kaesberg P. PMID: 32855756; PMCID: PMC7430864.
      View in: PubMed   Mentions: 1  
    19. Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry. EJHaem. 2020 Jul; 1(1):58-68. Pollyea DA, George TI, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, Grinblatt DL, Komrokji RS, Maciejewski JP, Revicki DA, Roboz GJ, Savona MR, Scott BL, Sekeres MA, Thompson MA, Kurtin SE, Louis CU, Nifenecker M, Flick ED, Swern AS, Kiselev P, Steensma DP, Erba HP. PMID: 35847712; PMCID: PMC9176048.
      View in: PubMed   Mentions: 4  
    20. A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies. Clin Lymphoma Myeloma Leuk. 2020 07; 20(7):453-458. Hoeg RT, Davis J, Jonas BA, Tuscano J, Rosenberg A, Abedi M. PMID: 32171691; PMCID: PMC8530379.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    21. A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia. Am J Hematol. 2019 11; 94(11):E291-E294. Tomlinson BK, Tuscano JM, Abedi M, Welborn J, Arora M, O'Donnell RT, Wun T, Jonas BA. PMID: 31379016.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    22. CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges. Cell Stem Cell. 2018 06 01; 22(6):801-805. Jamieson CHM, Millan MT, Creasey AA, Lomax G, Donohoe ME, Walters MC, Abedi M, Bota DA, Zaia JA, Adams JS. PMID: 29859170.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    23. Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice. Biol Blood Marrow Transplant. 2017 01; 23(1):30-37. Pai CS, Khuat LT, Chen M, Murphy WJ, Abedi M. PMID: 27815049; PMCID: PMC5469294.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    24. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study. BMC Cancer. 2016 08 19; 16:652. Steensma DP, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, George TI, Grinblatt D, Komrokji R, Ma X, Maciejewski J, Pollyea DA, Savona MR, Scott B, Sekeres MA, Thompson MA, Swern AS, Nifenecker M, Sugrue MM, Erba H. PMID: 27538433; PMCID: PMC4991094.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    25. Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response. Prostate. 2016 10; 76(14):1257-70. Junghans RP, Ma Q, Rathore R, Gomes EM, Bais AJ, Lo AS, Abedi M, Davies RA, Cabral HJ, Al-Homsi AS, Cohen SI. PMID: 27324746.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansCellsCTClinical Trials
    26. Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and Osteosclerosis. Cancers (Basel). 2015 Dec 14; 7(4):2459-65. Stelling A, Jonas BA, Rashidi HH, Abedi M, Chen M. PMID: 26694466; PMCID: PMC4695903.
      View in: PubMed   Mentions:
    27. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells. Stem Cells. 2015 Mar; 33(3):870-9. Barclay SL, Yang Y, Zhang S, Fong R, Barraza A, Nolta JA, Torbett BE, Abedi M, Bauer G, Anderson JS. PMID: 25524029.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    28. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest Ophthalmol Vis Sci. 2014 Dec 09; 56(1):81-9. Park SS, Bauer G, Abedi M, Pontow S, Panorgias A, Jonnal R, Zawadzki RJ, Werner JS, Nolta J. PMID: 25491299; PMCID: PMC4288143.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCellsCTClinical Trials
    29. Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1899-904. Pai CC, Hsiao HH, Sun K, Chen M, Hagino T, Tellez J, Mall C, Blazar BR, Monjazeb A, Abedi M, Murphy WJ. PMID: 25064746; PMCID: PMC4254314.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    30. Treatment of chronic graft-versus-host disease with bortezomib. Blood. 2014 Sep 04; 124(10):1677-88. Pai CC, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, Ames E, Sun K, Jagdeo J, Blazar BR, Murphy WJ, Abedi M. PMID: 25009225; PMCID: PMC4155274.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCellsCTClinical Trials
    31. Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013. Hum Gene Ther. 2014 Jun; 25(6):488-97. O'Reilly M, Federoff HJ, Fong Y, Kohn DB, Patterson AP, Ahmed N, Asokan A, Boye SE, Crystal RG, De Oliveira S, Gargiulo L, Harper SQ, Ikeda Y, Jambou R, Montgomery M, Prograis L, Rosenthal E, Sterman DH, Vandenberghe LH, Zoloth L, Abedi M, Adair J, Adusumilli PS, Goins WF, Gray J, Monahan P, Popplewell L, Sena-Esteves M, Tannous B, Weber T, Wierda W, Gopal-Srivastava R, McDonald CL, Rosenblum D, Corrigan-Curay J. PMID: 24773122; PMCID: PMC4064731.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    32. Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma. Br J Haematol. 2014 May; 165(3):375-81. Tuscano JM, Dutia M, Chee K, Brunson A, Reed-Pease C, Abedi M, Welborn J, O'Donnell RT. PMID: 24606326.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    33. Atypical lymphocytosis, cold agglutinin hemolytic anemia, and monoclonal gammopathy in an HIV patient with marrow involvement by diffuse large B-cell lymphoma. Blood. 2013 Nov 28; 122(23):3711. Chen M, Abedi M. PMID: 24427808.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    34. Multiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin's lymphoma: a pilot study. Bone Marrow Transplant. 2014 Jan; 49(1):73-9. Lum LG, Thakur A, Pray C, Kouttab N, Abedi M, Deol A, Colaiace WM, Rathore R. PMID: 24056738; PMCID: PMC3891305.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    35. The path(way) less traveled. Blood. 2013 Sep 19; 122(12):1996-7. Abedi M, Murphy WJ. PMID: 24052539.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    36. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation. J Immunol. 2012 Aug 15; 189(4):2033-42. Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, Welniak LA, Hagino T, Jagdeo J, Pai CC, Chen M, Blazar BR, Abedi M, Murphy WJ. PMID: 22778394; PMCID: PMC3509544.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    37. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol. 2012 May 11; 12(6):443-58. Blazar BR, Murphy WJ, Abedi M. PMID: 22576252; PMCID: PMC3552454.
      View in: PubMed   Mentions: 418     Fields:    Translation:HumansAnimalsCells
    38. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. J Virol. 2012 May; 86(10):5719-29. Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M, Bauer G, Nolta JA, Anderson JS. PMID: 22398281; PMCID: PMC3347262.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    39. Hematopoietic Origin of Fibrocytes. . 2011 Dec 1; 1-15. Abedi AM. .
      View in: Publisher Site   Mentions:
    40. Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci U S A. 2011 Jan 11; 108(2):762-7. Amenta AR, Yilmaz A, Bogdanovich S, McKechnie BA, Abedi M, Khurana TS, Fallon JR. PMID: 21187385; PMCID: PMC3021068.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansAnimalsCells
    41. Cytokines inducing bone marrow SCA+ cells migration into pancreatic islet and conversion into insulin-positive cells in vivo. PLoS One. 2009; 4(2):e4504. Luo L, Luo JZ, Xiong F, Abedi M, Greer D. PMID: 19225560; PMCID: PMC2637986.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    42. Conversion potential of marrow cells into lung cells fluctuates with cytokine-induced cell cycle. Stem Cells Dev. 2008 Apr; 17(2):207-19. Dooner MS, Aliotta JM, Pimentel J, Dooner GJ, Abedi M, Colvin G, Liu Q, Weier HU, Johnson KW, Quesenberry PJ. PMID: 18447637.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    43. Haematopoietic stem cells participate in muscle regeneration. Br J Haematol. 2007 Sep; 138(6):792-801. Abedi M, Foster BM, Wood KD, Colvin GA, McLean SD, Johnson KW, Greer DA. PMID: 17672885.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    44. Stem cell continuum: directed differentiation hotspots. Exp Hematol. 2007 Jan; 35(1):96-107. Colvin GA, Dooner MS, Dooner GJ, Sanchez-Guijo FM, Demers DA, Abedi M, Ramanathan M, Chung S, Pascual S, Quesenberry PJ. PMID: 17198878.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    45. Adult Stem Cell Plasticity: Lineage Potential on a Continuum. . 2007 Jan 1; 11-23. Quesenberry QP, Colvin CG, Abedi AM. .
      View in: Publisher Site   Mentions:
    46. Bone marrow production of lung cells: the impact of G-CSF, cardiotoxin, graded doses of irradiation, and subpopulation phenotype. Exp Hematol. 2006 Feb; 34(2):230-41. Aliotta JM, Keaney P, Passero M, Dooner MS, Pimentel J, Greer D, Demers D, Foster B, Peterson A, Dooner G, Theise ND, Abedi M, Colvin GA, Quesenberry PJ. PMID: 16459191; PMCID: PMC1986763.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    47. The stem cell continuum. Ann N Y Acad Sci. 2005 Jun; 1044:228-35. Quesenberry PJ, Colvin GA, Abedi M, Dooner G, Dooner M, Aliotta J, Keaney P, Luo L, Demers D, Peterson A, Foster B, Greer D. PMID: 15958716.
      View in: PubMed   Mentions: 6     Fields:    Translation:Cells
    48. Developmental biology: Ignoratio elenchi: red herrings in stem cell research. Science. 2005 May 20; 308(5725):1121-2. Quesenberry PJ, Dooner G, Dooner M, Abedi M. PMID: 15905387.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    49. Critical variables in the conversion of marrow cells to skeletal muscle. Blood. 2005 Aug 15; 106(4):1488-94. Abedi M, Greer DA, Foster BM, Colvin GA, Harpel JA, Demers DA, Pimentel J, Dooner MS, Quesenberry PJ. PMID: 15870176; PMCID: PMC1895200.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    50. Stem cell biology and the plasticity polemic. Exp Hematol. 2005 Apr; 33(4):389-94. Quesenberry PJ, Dooner G, Colvin G, Abedi M. PMID: 15781328.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    51. Perspective: fundamental and clinical concepts on stem cell homing and engraftment: a journey to niches and beyond. Exp Hematol. 2005 Jan; 33(1):9-19. Quesenberry PJ, Colvin G, Abedi M. PMID: 15661393.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    52. The marrow cell continuum: stochastic determinism. Folia Histochem Cytobiol. 2005; 43(4):187-90. Quesenberry P, Abedi M, Dooner M, Colvin G, Sanchez-Guijo FM, Aliotta J, Pimentel J, Dooner G, Greer D, Demers D, Keaney P, Peterson A, Luo L, Foster B. PMID: 16382882.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    53. Robust conversion of marrow cells to skeletal muscle with formation of marrow-derived muscle cell colonies: a multifactorial process. Exp Hematol. 2004 May; 32(5):426-34. Abedi M, Greer DA, Colvin GA, Demers DA, Dooner MS, Harpel JA, Weier HU, Lambert JF, Quesenberry PJ. PMID: 15145210.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    54. Intrinsic hematopoietic stem cell/progenitor plasticity: Inversions. J Cell Physiol. 2004 Apr; 199(1):20-31. Colvin GA, Lambert JF, Moore BE, Carlson JE, Dooner MS, Abedi M, Cerny J, Quesenberry PJ. PMID: 14978731.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    55. Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology. Leukemia. 2004 Mar; 18(3):575-83. Colvin GA, Lambert JF, Abedi M, Hsieh CC, Carlson JE, Stewart FM, Quesenberry PJ. PMID: 14749701.
      View in: PubMed   Mentions: 46     Fields:    Translation:AnimalsCells
    56. Differentiation hotspots: the deterioration of hierarchy and stochasm. Blood Cells Mol Dis. 2004 Jan-Feb; 32(1):34-41. Colvin GA, Lambert JF, Abedi M, Dooner MS, Demers D, Moore BE, Greer D, Aliotta JM, Pimentel J, Cerny J, Lum LG, Quesenberry PJ. PMID: 14757410.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    57. Tissue injury in marrow transdifferentiation. Blood Cells Mol Dis. 2004 Jan-Feb; 32(1):42-6. Abedi M, Greer DA, Colvin GA, Demers DA, Dooner MS, Harpel JA, Pimentel J, Menon MK, Quesenberry PJ. PMID: 14757411.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    58. Stem cell plasticity: an overview. Blood Cells Mol Dis. 2004 Jan-Feb; 32(1):1-4. Quesenberry PJ, Abedi M, Aliotta J, Colvin G, Demers D, Dooner M, Greer D, Hebert H, Menon MK, Pimentel J, Paggioli D. PMID: 14757404.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    59. Homing and conversion of murine hematopoietic stem cells to lung. Blood Cells Mol Dis. 2004 Jan-Feb; 32(1):47-51. Dooner M, Cerny J, Colvin G, Demers D, Pimentel J, Greer D, Abedi M, McAuliffe C, Quesenberry P. PMID: 14757412.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    60. Targeting of Lin-Sca+ hematopoietic stem cells with bispecific antibodies to injured myocardium. Blood Cells Mol Dis. 2004 Jan-Feb; 32(1):82-7. Lum LG, Fok H, Sievers R, Abedi M, Quesenberry PJ, Lee RJ. PMID: 14757418.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    61. Tolerance induction by costimulator blockade in 100 cGy treated hosts with varying degrees of genetic disparity. Leukemia. 2003 Sep; 17(9):1871-9. Abedi M, Greer D, Lambert JF, Colvin GA, Dooner MS, McAuliffe CI, Demers D, Moore BE, Quesenberry PJ. PMID: 12970789.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    62. The marrow stem cell: the continuum. Bone Marrow Transplant. 2003 Aug; 32 Suppl 1:S19-22. Quesenberry PJ, Colvin GA, Abedi M, Lambert JF, Moore B, Demers D, Greer D, McAuliffe C, Dooner M, Lum LG, Badiavas E, Falanga V. PMID: 12931234.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    63. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol. 2003 Aug; 196(2):245-50. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. PMID: 12811816.
      View in: PubMed   Mentions: 110     Fields:    Translation:AnimalsCells
    64. Novel approaches in the treatment of multiple myeloma. Med Health R I. 2003 Aug; 86(8):231-5. Abedi M, Elfenbein GJ. PMID: 14582216.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Marrow stem cell potential within a continuum. Ann N Y Acad Sci. 2003 May; 996:209-21. Quesenberry P, Colvin G, Lambert JF, Abedi M, Cerny J, Dooner M, Moore B, McAuliffe C, Demers D, Greer D, Parent A, Badiavas E, Lum L, Falanga V. PMID: 12799298.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    66. H2-mismatched transplantation with repetitive cell infusions and CD40 ligand antibody infusions without myeloablation. Br J Haematol. 2002 Oct; 119(1):155-63. Lambert JF, Colvin GA, Zhong S, Wang H, D'Hondt L, Abedi M, Frimberger AE, Stewart FM, Quesenberry PJ. PMID: 12358920.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    67. Rhythmicity of engraftment and altered cell cycle kinetics of cytokine-cultured murine marrow in simulated microgravity compared with static cultures. In Vitro Cell Dev Biol Anim. 2002 Jun; 38(6):343-51. Colvin GA, Lambert JF, Carlson JE, McAuliffe CI, Abedi M, Quesenberry PJ. PMID: 12513122.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    68. Host marrow stem cell potential and engraftability at varying times after low-dose whole-body irradiation. Blood. 2001 Aug 15; 98(4):1246-51. Stewart FM, Zhong S, Lambert JF, Colvin GA, Abedi M, Dooner MS, McAuliffe CI, Wang H, Hsieh C, Quesenberry PJ. PMID: 11493477.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    69. Stem cell engraftment strategies. Ann N Y Acad Sci. 2001 Jun; 938:54-61; discussion 61-2. Quesenberry PJ, Stewart FM, Becker P, D'Hondt L, Frimberger A, Lambert JF, Colvin GA, Miller C, Heyes C, Abedi M, Dooner M, Carlson J, Reilly J, McAuliffe C, Stencel K, Ballen K, Emmons R, Doyle P, Zhong S, Wang H, Habibian H. PMID: 11458526.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    With one click, see people who:

    Mentor

    Offer Student Projects

    Run Clinical Trials

    See more options in the Advanced Search tab

    Mehrdad's Networks
    Concepts (305)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (45)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California